Stay updated on Dociparstat Sodium with Standard Induction in AML Clinical Trial
Sign up to get notified when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.

Latest updates to the Dociparstat Sodium with Standard Induction in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no study details or functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 with minor UI/functional updates that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved the site-wide funding/operating status banner from the page; this change does not affect trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedScreenshots indicate only minor UI/layout adjustments with no changes to core trial details (title, condition, eligibility, arms, or primary outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedCore content updated with new entity (Jazz Pharmaceuticals) and removal of an existing one (Chimerix); version bumped to v3.2.0, and a government funding/operating-status notice added.SummaryDifference3%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Dociparstat Sodium with Standard Induction in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.